Clinical Trials Browser

Terminated × OTHER × vedolizumab × Clear all

NCT02768532 2023-06-15

VEDO-PREDIRESP

Phase 4 Terminated

Crohn Disease

NCT03802214 2020-12-21

Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy

Colitis, Ulcerative